Candriam Equities L Oncology Impact I/ LU1864482358 /
NAV9/19/2024 | Chg.+22.3499 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
3,098.3899USD | +0.73% | reinvestment | Equity | Candriam ▶ |
Performance | Volatility | Sharpe ratio |
---|---|---|
NAV9/19/2024 | Chg.+22.3499 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
3,098.3899USD | +0.73% | reinvestment | Equity | Candriam ▶ |
Performance | Volatility | Sharpe ratio |
---|---|---|